Genscript Biotech (GNNSF) Q1 2026 Earnings

Mar 15Confirmed
Q3 2024
Q1 2025
Q3 2025
Q1 2026
-0.23
0.34
0.91
1.48

Details

Expected EPS
-0.03
Actual EPS
-0.23
Surprise EPS
-0.2
Surprise Percent
-666.67%

Description

⁨Genscript Biotech⁩ (⁦GNNSF⁩) has reported earnings of ⁦-0.23⁩ per share for ⁦Q1 2026⁩.

0 Comments

Share your thoughts